-
Morning Buzz: Portola Pharmaceuticals (NASDAQ:PTLA), Denbury Resources (NYSE:DNR), Canadian Imperial Bank of Commerce (NYSE:CM), Fortune Brands Home & Security (NYSE:FBHS), PAHC
On Wednesday shares of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) closed at $39.45. On 8 April, Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) announced positive topline results from the second part of the Phase 3 ANNEXA™-A study, which evaluated the safety and efficacy of and exanet alfa, an investigational antidote, with the Factor Xa inhibitor Eliquis (apixaban) in healthy volunteers.…
-
Trending Tickers: Culp (NYSE:CFI), Portola Pharmaceuticals (NASDAQ:PTLA), Zynga Inc (NASDAQ:ZNGA), Owens-Illinois (NYSE:OI), Sohu.com Inc. (NASDAQ:SOHU)
On Monday shares of Culp, Inc. (NYSE:CFI) closed at $26.50. Company’s sales growth for last 5 years was 7.10% and EPS growth for next 5 years is recorded as 9.00%. Culp, Inc. (NYSE:CFI) was downgraded by stock analysts at Raymond James from an “outperform” rating to a “market perform” rating in a report issued on…
-
Trader’s Watch List: Epizyme (NASDAQ:EPZM), Yandex N.V. (NASDAQ:YNDX), Citigroup Inc. (NYSE:C), Portola Pharmaceuticals (NASDAQ:PTLA), Frontline (NYSE:FRO)
On Monday shares of Epizyme, Inc. (NASDAQ:EPZM) closed at $19.74. Epizyme, Inc. (NASDAQ:EPZM) announced that data from its preclinical pipeline will be presented during the American Association for Cancer Research (AACR) Annual Meeting, to be held April 18-25 in Philadelphia, Pa. Yandex N.V. (NASDAQ:YNDX) in last trading activity fell -0.03% to close at $17.83. Company…
-
Worth Watching Stocks: Portola Pharmaceuticals (NASDAQ:PTLA), Groupon (NASDAQ:GRPN), Biogen Inc. (NASDAQ:BIIB), Ford Motor Company (NYSE:F), 3M Company (NYSE:MMM)
On Thursday shares of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) closed at $37.24. Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) had its target price boosted by Credit Suisse to $51.00 in a report issued on Tuesday. Groupon, Inc. (NASDAQ:GRPN) in last trading activity increased 0.57% to close at $7.06. Company weekly performance is -6.86% while its quarterly performance stands at…
-
Traders Buzz: United States Steel Corp. (NYSE:X), Portola Pharmaceuticals (NASDAQ:PTLA), Union Pacific Corporation (NYSE:UNP), Redwood Trust (NYSE:RWT), YRC Worldwide (NASDAQ:YRCW)
United States Steel Corporation (NYSE:X) announced it will temporarily idle its Minnesota Ore Operations – Keetac plant in Keewatin, Minn., effective May 13. The temporary idling is due to the company’s current inventory levels and ongoing adjustment of its steelmaking operations throughout North America to match customer demand. On Thursday shares of United States Steel…
-
Stay on: ICICI Bank (NYSE:IBN), IAMGOLD Corp. (NYSE:IAG), Portola Pharmaceuticals (NASDAQ:PTLA), EMC Corporation (NYSE:EMC), UIL Holdings Corporation (NYSE:UIL)
ICICI Bank Ltd. (NYSE:IBN) has invited online applications for its Probationary Officer training programme. There will be two batches that will start undergoing the training at the ICICI Manipal Academy for Banking and Insurance (IMA) in the first week of November 2015 and in February 2016. On Thursday shares of ICICI Bank Ltd. (NYSE:IBN) closed…
-
Top Stocks: 500.com Limited (NYSE:WBAI), J C Penney Company Inc (NYSE:JCP), Portola Pharmaceuticals (NASDAQ:PTLA), Prudential Bancorp (NASDAQ:PBIP), The Dow Chemical (NYSE:DOW)
500.com Limited (NYSE:WBAI) announced that it had recently come to the Company’s attention that certain provincial sports lottery administration centers to which the Company provides sport lottery sales services plan to temporarily suspend accepting online purchase orders for lottery products, in response to the Notice on Issues Related to Self-Inspection and Self-Remedy of Unauthorized Online…
-
Biotech Gainers in Spotlight: Genetic Technologies Limited (NASDAQ:GENE), Cambrex Corporation. (NYSE:CBM), Portola Pharmaceuticals (NASDAQ:PTLA), Coherus Biosciences (NASDAQ:CHRS), Vericel Corporation (NASDAQ:VCEL)
On 29 January, Genetic Technologies Limited (NASDAQ: GENE) reported that up to 6 new breast diagnosis/treatment centres are expected to begin offering BREVAGenplus® to their at-risk patients in a systematic broad fashion in the January to March timeframe, with a growing number of additional new breast and imaging centre customers expected to follow later in…
-
Mix Sector Stocks: BlackBerry Ltd (NASDAQ:BBRY), Kinder Morgan (NYSE:KMI), SM Energy Company (NYSE:SM), Microsemi Corporation (NASDAQ:MSCC), Portola Pharmaceuticals (NASDAQ:PTLA)
On 26 January, BlackBerry Ltd (NASDAQ:BBRY) said that Samsung Electronics offered to buy BlackBerry Ltd for as much as $7.5 billion. On Friday shares of BlackBerry Ltd (NASDAQ:BBRY) closed at $9.98. Company’s sales growth for last 5 years was -9.20% and EPS growth for next 5 years is recorded as 54.20%. On 3 February, Kinder…
-
Market Watch List: Portola Pharmaceuticals (NASDAQ:PTLA), Opko Health (NYSE:OPK), Bellatrix Exploration (NYSE:BXE), Konami Corp. (NYSE:KNM), Steiner Leisure (NASDAQ:STNR)
Portola Pharmaceuticals (Nasdaq:PTLA) announced that the Independent Data Monitoring Committee (IDMC) recommended that the Phase 3 APEX (Acute Medically Ill VTE Prevention with Extended Duration Betrixaban) Study of betrixaban continue as planned without modification based on the successful completion of a pre-specified futility analysis. In making this recommendation, the IDMC evaluated preliminary efficacy trends and…